Clinical Trial Update: A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis [Phase 2]

View source ↗

Summary

Phase II surgical debulking with biweekly intraperitoneal 5-FU plus systemic oxaliplatin/5-FU/leucovorin for pseudomyxoma peritonei or peritoneal carcinomatosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Carcinomatosis
• Pseudomyxoma Peritonei

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Peritoneal Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2016-12-13